The firm plans to launch several products based on its proprietary machine learning method for identifying variants that alter cellular biochemistry and cause disease.
The method combines post-translational modification data and 3D protein structure data to identify known and novel biologically significant hotspots.
The partners will continue to develop an integrated sequence and knowledge database to support Pierre Fabre's therapeutic antibody development efforts.
Researchers at the Manchester Centre for Genomic Medicine are using the platform to identify genetic alterations tied to cancer and developmental disorders and disabilities.
The companylaunched GenomeStack, its first product for the life science market, earlier this year at the Bio-IT World Conference and Expo in Boston.
The tool uses whole genome sequence from M. tuberculosis strains to predict genetic resistance to tuberculosis drugs faster than traditional culture-based methods.
CICGD scientists will use the NextCode technology to accelerate research, clinical diagnosis, and treatment of rare inherited diseases and malignant tumors.
The company made the move after several media outlets falsely reported that Ancestry had divulged the identify of a donor without a police warrant.
ARUP's database is one of many options that researchers and oncologists can use to learn about whether alterations in BRCA genes are associated with hereditary breast and ovarian cancer risk.
Under the terms of the agreement, SolveBio will distribute OncoMD, MedGenome's cancer mutation knowledgebase.
The New York City Police Department will be removing DNA profiles from a local database if they are from people who were never convicted of a crime, the New York Times reports.
Science reports that accusations of sexual assault against a microbiome researcher has also led to questions about his academic certifications.
Wired reports that researchers are analyzing the DNA fish leave behind in water to study their populations.
In Science this week: comprehensive cellular map of the human thymus, evidence of admixture between the ancestors of Neanderthals and Denisovan and a 'superarchaic' population.